OMB.report

Federal forms, ICRs, and supporting documents

Information Collection Request

Prevent Hepatitis Transmission among Persons who Inject Drugs

ICR 201601-0920-007 · OMB 0920-1116 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
Follow-up Survey Form New Repair queued
Initial Survey Form New Available
Screener Form New Available
Supporting Statement A1.docx Supporting Statement A Uploaded 2016-06-09 Available
CDC ProjectDetermination.pdf Supplementary Document Uploaded 2016-01-11 Repair queued
Att 6B UNM ConsentForm.pdf Supplementary Document Uploaded 2016-01-11 Repair queued
Att 6A UC ConsentForm.docx Supplementary Document Uploaded 2016-01-11 Available
Att 5E CoC UNM.pdf Supplementary Document Uploaded 2016-01-11 Available
Att 5D CoC UC.pdf Supplementary Document Uploaded 2016-01-11 Available
Att 5B UNM IRB.pdf Supplementary Document Uploaded 2016-01-11 Available
Att 5A UC IRB.pdf Supplementary Document Uploaded 2016-01-11 Repair queued
Att 4B UNM Protocol.doc Supplementary Document Uploaded 2016-01-11 Available
Att 4A UC Protocol.docx Supplementary Document Uploaded 2016-01-11 Available
Att 2B.docx Supplementary Document Uploaded 2016-01-11 Available
Att 2A.pdf Supplementary Document Uploaded 2016-01-11 Available
Att 2 60-Day FRN.pdf Supplementary Document Uploaded 2016-01-11 Repair queued
Att 1 AuthLegislation.doc Supplementary Document Uploaded 2016-01-11 Available
Supporting Statement B.doc Supporting Statement B Uploaded 2016-06-09 Available
IC Document Collections
IC IDCollectionTypeStatusForm
219539 Follow-up Survey Form New
219538 Initial Survey Form New
219537 Screener Form New
ICR Details
0920-1116 201601-0920-007
Historical Active
HHS/CDC 15ARG
Prevent Hepatitis Transmission among Persons who Inject Drugs
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 06/09/2016
Retrieve Notice of Action (NOA) 01/19/2016
Approved consistent with the understanding that respondents are selected using convenience sampling and will not be representative of the national population of persons who inject drugs (PWID). Any reporting or publication of outcomes will be accompanied by a discussion of any limitations posed by the recruitment and sampling methodologies.
  Inventory as of this Action Requested Previously Approved
06/30/2019 36 Months From Approved
1,822 0 0
949 0 0
0 0 0
This study addresses the high prevalence of HCV infection by developing an integrated approach for detection, prevention, care and treatment of infection among persons aged 18-30 years who reside in non-urban counties. In addition to providing HCV testing, participants will be offered testing for the presence of co-infections with hepatitis B virus (HBV) and HIV. Adherence to prevention services and retention in care will be assessed through follow up interviews. HCV re-infection will be determined through follow-up blood tests.
US Code: 42 USC 241 Name of Law: PHSA
  
None
Not associated with rulemaking
  80 FR 37264 06/30/2015
81 FR 1951 01/14/2016
Yes
3
IC Title Form No. Form Name
Initial Survey none Initial Survey
Screener none Screener
Follow-up Survey none Follow-up Survey
  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1,822 0 0 1,822 0 0
Annual Time Burden (Hours) 949 0 0 949 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new ICR.
$447,000
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Shari Steinberg 404 639-4942 [email protected]
  No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/19/2016